Drug Shortage and Critical Medication Inventory Management at a Children's Hospital During the COVID-19 Pandemic.
COVID-19
inventories, hospital
medication systems, hospital
pediatric
surge capacity
Journal
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG
ISSN: 1551-6776
Titre abrégé: J Pediatr Pharmacol Ther
Pays: United States
ID NLM: 101089851
Informations de publication
Date de publication:
2021
2021
Historique:
received:
27
08
2020
accepted:
14
10
2020
entrez:
11
1
2021
pubmed:
12
1
2021
medline:
12
1
2021
Statut:
ppublish
Résumé
Drug shortages have significantly affected the ability to provide care at pediatric institutions, particularly in the inpatient and critical care settings. The coronavirus disease 2019 (COVID-19) pandemic highlighted additional challenges with drug supply chains. A working group consisting of pharmacy management, clinical pharmacists, and pharmacy buyers met regularly at the beginning of the COVID-19 pandemic. In collaboration with medical staff leadership and the Pharmacy and Therapeutics Committee, we developed a pediatric critical drug list to track essential medications for targeted monitoring. We created an inventory model with easily modifiable input variables related to patient and hospital data. This model was aligned across affiliate health care systems to increase transparency of our hospital's surge capacity for managing patients with COVID-19. Here, we share our framework for modeling drug inventory management at a freestanding children's hospital during a global pandemic.
Identifiants
pubmed: 33424496
doi: 10.5863/1551-6776-26.1.21
pmc: PMC7792151
doi:
Types de publication
Journal Article
Langues
eng
Pagination
21-25Informations de copyright
Copyright Pediatric Pharmacy Association. All rights reserved. For permissions, email: mhelms@pediatricpharmacy.org 2021.
Déclaration de conflit d'intérêts
Disclosures. The authors declare no conflicts or financial interest in any product or service mentioned in the manuscript, including grants, equipment, medications, employment, gifts, and honoraria. The corresponding author had full access to all data and takes responsibility for the integrity and accuracy of the data analysis.
Références
J Pediatr Pharmacol Ther. 2015 Mar-Apr;20(2):149-52
pubmed: 25964733
JAMA. 2020 Jul 7;324(1):31-32
pubmed: 32271871
JAMA. 2020 Apr 21;323(15):1441-1442
pubmed: 32167525
Am J Health Syst Pharm. 2018 Nov 1;75(21):1742-1750
pubmed: 30061155
J Trauma. 2009 Aug;67(2 Suppl):S140-2
pubmed: 19667847
Pediatr Blood Cancer. 2015 Jun;62(6):931-4
pubmed: 25732614
Ann Am Thorac Soc. 2020 Aug;17(8):928-931
pubmed: 32492353
J Clin Anesth. 2012 Dec;24(8):677-9
pubmed: 23228874
Chest. 2014 Oct;146(4 Suppl):e1S-e16S
pubmed: 25144334
Am J Disaster Med. 2017 Fall;12(4):203-226
pubmed: 29468624
Disaster Med Public Health Prep. 2020 Sep 10;:1-8
pubmed: 32907668
Pediatrics. 2012 Nov;130(5):e1369-73
pubmed: 23045557